Fluids are not a standard treatment for most cardiogenic shock, but they are not categorically off-limits either. The answer depends entirely on which side of the heart is failing and whether the patient’s circulation will actually respond to more volume. In left-sided cardiogenic shock, the lungs are typically already congested, and adding fluid makes things worse. In right ventricular failure, a careful fluid challenge is often the first step, though even here, too much fluid can backfire.
Why Cardiogenic Shock Is Different From Other Shock
In most types of shock (septic, hemorrhagic), the problem is not enough blood returning to the heart, so fluids are the obvious fix. Cardiogenic shock flips that logic. The heart itself is the problem: it cannot pump effectively, so blood backs up behind it. Pushing more fluid into a system that is already overfilled raises pressure in the lungs, worsens oxygen exchange, and can accelerate organ damage.
The European Society of Cardiology defines cardiogenic shock as a systolic blood pressure below 90 mmHg despite appropriate fluid resuscitation, combined with signs of poor organ perfusion like cold extremities, low urine output, confusion, rising lactate levels, and worsening kidney function. Notice the phrase “despite appropriate fluid resuscitation.” That language acknowledges a limited role for fluids before other interventions take over.
When Fluids Are Given: Right Ventricular Failure
The clearest scenario for fluid administration is cardiogenic shock caused by a right ventricular infarction. The right ventricle depends on adequate filling pressure to push blood through the lungs. When it fails, blood pools in the veins and the lungs stay relatively dry. In this specific pattern, volume expansion is traditionally the first-line therapy for hypotension.
A typical regimen involves normal saline given intravenously at roughly 40 mL per minute, up to a total of about 2 liters, while monitoring right atrial pressure to keep it below 18 mmHg. Research published in the European Heart Journal found that the right ventricle performs best when filling pressure sits between 10 and 14 mmHg. Once right atrial pressure climbs above 14 mmHg, pumping efficiency actually drops.
The reason is a concept called ventricular interdependence. The right and left ventricles share a wall (the septum) and sit inside the same pericardial sac. When the right ventricle becomes overdistended with fluid, it pushes the septum into the left ventricle, compresses it, and reduces overall cardiac output. So even in the one scenario where fluids are clearly indicated, there is a narrow therapeutic window. Too little volume means inadequate filling; too much volume makes the shock worse.
How a Fluid Challenge Works
When clinicians suspect a patient might benefit from volume, they don’t simply open the IV wide. They use a structured fluid challenge: a small, controlled bolus given over a short period while watching specific hemodynamic markers. The standard approach uses about 4 mL per kilogram of body weight (roughly 200 to 300 mL for most adults) infused over 5 to 10 minutes. The goal is a measurable increase in cardiac output of at least 10%. If cardiac output rises, the patient is considered “fluid responsive,” and more volume may help. If it doesn’t, fluids are stopped.
A structured mnemonic called TROL guides the process: Type of fluid (usually a crystalloid like saline), Rate of infusion, Objective (the target cardiac output increase), and Limits (a ceiling for central venous pressure beyond which infusion stops). In cardiogenic shock specifically, this protocol is considered essential because the margin for error is so small.
Only About Half of Patients Respond
A study evaluating 41 patients with cardiogenic shock from acute coronary syndromes found that only 48.8% were fluid responsive. That means roughly half of these patients saw no hemodynamic benefit from additional volume. Interestingly, survival rates were not significantly different between responders and non-responders, which underscores that fluid responsiveness alone doesn’t determine outcomes. The takeaway is that giving fluids empirically, without testing whether the patient will respond, means roughly a coin flip chance of helping and a real chance of causing harm.
Testing Without Giving Fluid
One way to check fluid responsiveness without actually infusing anything is the passive leg raise test. Lifting the patient’s legs to about 45 degrees while keeping the torso flat shifts roughly 300 mL of venous blood from the legs back toward the heart. If cardiac output increases meaningfully, the patient is likely to benefit from volume. If it doesn’t, fluids can be withheld. Because the effect reverses the moment the legs come down, the test carries no risk of fluid overload.
The key requirement is that cardiac output must be measured directly during the test, typically with bedside ultrasound or another real-time monitor. Simply watching blood pressure is not reliable enough, because pressure can remain stable even when output changes.
When Fluids Cause Harm
Fluid overload is a serious concern in cardiogenic shock. A large observational study in Frontiers in Medicine found that patients discharged from intensive care with more than 5% fluid overload had 30-day mortality of 22.7%, compared to 11.7% in those without fluid overload. When fluid overload exceeded 10% of body weight, it was an independent predictor of death within 30 days, with more than triple the odds of mortality.
In left-sided cardiogenic shock, the left ventricle cannot effectively eject blood forward. Fluid backs up into the lungs, causing pulmonary edema that worsens breathing and oxygen levels. The pulmonary capillary wedge pressure, a measure of this backup, is typically already above 15 mmHg in cardiogenic shock. General guidance suggests keeping this pressure between 12 and 14 mmHg during fluid resuscitation in other forms of shock, but in cardiogenic shock it is usually already well past that threshold, which is precisely why fluids are harmful in this setting.
Detecting Congestion With Ultrasound
A newer tool called the VExUS score helps clinicians gauge venous congestion at the bedside using ultrasound. It combines the diameter of the large vein entering the heart (the inferior vena cava) with blood flow patterns in the liver, kidneys, and portal system. The score runs from grade 0 (no congestion) to grade 3 (severe congestion with abnormal flow in multiple organs).
What makes VExUS particularly useful in cardiogenic shock is that it reflects whether the cardiovascular system can handle its current volume, not just whether total volume is high or low. A patient in cardiogenic shock can show severe congestion even with a relatively normal total fluid balance, because the failing heart cannot accommodate the volume that is already there. When the score is grade 2 or higher with impaired heart function, the typical approach combines fluid removal with medications that support the heart’s pumping ability, rather than adding more volume.
What Comes After Fluids
For the majority of cardiogenic shock cases, medications that strengthen the heart’s contractions (inotropes) and those that support blood pressure (vasopressors) are the primary treatments. These are indicated once there is evidence of poor tissue perfusion despite adequate volume status. In practice, “adequate volume status” often means a brief, monitored fluid challenge that either helped or didn’t, followed by a rapid transition to pharmacologic support.
The staging system used in major clinical trials classifies classic cardiogenic shock as the point where the patient needs pharmacological or mechanical support beyond volume resuscitation to restore perfusion. By this definition, fluids are part of the initial evaluation, not the definitive treatment. They are a diagnostic step as much as a therapeutic one: the response to a small fluid bolus helps determine what the heart actually needs next.